ZURICH, April 22 — Roche said today that it would invest US$50 billion (RM219 billion) in the United States over the next five years, creating more than 12,000 new jobs, in the latest massive investment by companies reacting to President Donald Trump’s tariffs policy.

FRANKFURT, March 19 — Swiss drugmaker Roche has abandoned global targets for a more diverse workforce to avoid penalties from recent United States executive orders, the latest in a slew of companies to do so.

BASEL, July 17 — Roche said today a second drug candidate from its purchase of Carmot Therapeutics yielded positive results in an early-stage trial, as the Swiss drugmaker asserted itself as a late contender in the race to develop obesity drugs.

ZURICH/FRANKFURT, Oct 23 — Roche on Monday said it will buy Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial US$7.1 billion from US biotech firm Roivant Holdings and Pfizer Inc.

GENEVA, May 26 — Swiss multinational healthcare company Roche said on Wednesday that it has developed three test kits to detect the monkeypox virus, which has recently been spreading outside its epidemic areas in Africa.